ÂÜÀòÂÒÂ×

Pao-Chen Li, Ph.D., is a seasoned professional in clinical development, specializing in oncology. They have held various positions, including Manager of Regulatory Project Management at Gilead Sciences, where they managed submissions for multiple marketed and developing products. As a Postdoctoral Fellow at The J. David Gladstone Institutes, they introduced new gene editing technologies and collaborated on significant HIV research efforts. Pao-Chen is currently pursuing a Doctor of Philosophy at the University of Southern California and holds additional degrees from National Taiwan University and National Tsing Hua University.